- active not recruitingNA
Mechanisms of Disuse Atrophy in Human Skeletal Muscle (iMOB)
This study looks at why muscles get weaker and smaller when they're not used, like after an injury. We want to understand how this muscle loss happens, why some muscles are affected more than others, and if it's different for younger and older people.
United Kingdom - active not recruitingPHASE3
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
This study looks at the long-term safety and effects of a medicine called apitegromab for people with Spinal Muscular Atrophy (SMA) types 2 and 3. It's for those who have already completed earlier studies with this drug.
United States · Belgium · France